fluorodeoxyglucose f18 has been researched along with Bone Marrow Neoplasms in 76 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.32) | 18.2507 |
2000's | 26 (34.21) | 29.6817 |
2010's | 38 (50.00) | 24.3611 |
2020's | 11 (14.47) | 2.80 |
Authors | Studies |
---|---|
Ahn, JS; Ahn, SY; Jung, SH; Kim, HJ; Kim, M; Lee, JH; Lee, JJ; Shin, MG; Song, GY; Song, SY; Yang, DH | 1 |
Bachmann, IM; Haslerud, TM; Helgeland, L; Karlsdottir, Å; Reikvam, H; Thunestvedt, LMØ | 1 |
Bahri, H; Bouhamama, A; Brahmi, M; Corradini, N; Delattre, O; Guinot, A; Isnardi, V; Lapouble, E; Marec-Bérard, P; Pierron, G; Surdez, D; Tabone-Eglinger, S; Villemeur, M | 1 |
Abougabal, AM; El-Noueam, K; Ettaby, A; Fadel, S; Soliman, H | 1 |
Alsayed, Y; Edesa, W; Hussein, M; Kandeel, AA; Younis, J; Zidan, L | 1 |
Fujiwara, K; Ishida, H; Kanamitsu, K; Shimada, A; Tsukahara, H; Washio, K | 1 |
Cheng, J; Ou, X | 1 |
Campbell, KM; DuBois, SG; Grier, HE; Shulman, DS | 1 |
Chen, P; Jiang, M; Zheng, J | 1 |
Cao, J; Chen, Y; Huang, Y; Liu, H; Peng, D | 1 |
Barton, H; Charles-Edwards, E; Chevassut, T; Dizdarevic, S; Teagle, AR | 1 |
Bagatell, R; Berthold, F; Boubaker, A; Brock, P; Burchill, S; Cohn, SL; Ladenstein, R; Lindwasser, OW; London, WB; Maris, JM; Matthay, KK; McHugh, K; Nuchtern, JG; Park, JR; Pearson, AD; Schleiermacher, G; Seibel, NL; Valteau-Couanet, D; Villablanca, JG | 1 |
Dong, P; Li, L; Su, M; Tian, R | 1 |
Chen, S; Fu, H; He, K; Ma, C; Wang, H; Wang, S | 1 |
Murakami, T; Nogami, M; Shirai, T; Zen, Y; Zeng, F | 1 |
Ammann, RA; Attarbaschi, A; Balwierz, W; Baumann, J; Beishuizen, A; Cepelova, M; Chavdarova, L; Daw, S; Dieckmann, K; Fernández-Teijeiro, A; Fosså, A; Georgi, TW; Hasenclever, D; Hraskova, A; Karlen, J; Kluge, R; Körholz, D; Kurch, L; Landman-Parker, J; Leblanc, T; Mauz-Körholz, C; Pears, J; Pelz, T; Sabri, O; Stoevesandt, D; Uyttebroeck, A; Wallace, WH | 1 |
Kang, KW; Kim, I; Koh, Y; Lee, JM; Paeng, JC; Woo, GU; Yoon, SS; Youk, J | 1 |
Adamhasan, F; Koçyiğit-Deveci, E; Küpeli, S; Yağci-Küpeli, B | 1 |
Hara, T; Hashimoto, R; Minami, M; Suzuki, H; Takahashi, H | 1 |
Achmad, A; Arisaka, Y; Higuchi, T; Kim, M; Miyashita, G; Miyazaki, H; Negishi, A; Tokue, A; Tominaga, H; Tsushima, Y; Yokoo, S | 1 |
Chang, CC; Chen, YW; Hou, MF; Huang, CJ; Lin, CY; Yang, WC | 1 |
Adam, JA; Adams, HJ; de Keizer, B; de Klerk, JM; Fijnheer, R; Kersten, MJ; Kwee, TC; Nievelstein, RA; Stoker, J; Vermoolen, MA | 1 |
Agrawal, A; Purandare, N; Puranik, AD; Rangarajan, V; Shah, S | 1 |
Dong, A; Gao, L; Wang, Y; Zuo, C | 1 |
Ishigatsubo, Y; Kaneko, T; Nagai, K; Shinkai, M; Watanabe, K; Yamaguchi, N | 1 |
Yang, J; Zhen, L; Zhuang, H | 1 |
Adams, HJ; de Keizer, B; de Klerk, JM; Fijnheer, R; Kwee, TC; Littooij, AS; Nievelstein, RA | 1 |
Adams, HJ; Blase, PE; de Klerk, JM; Dubois, SV; Fijnheer, R; Kwee, TC; Nievelstein, RA | 1 |
Barrington, SF; Cavalli, F; Cheson, BD; Fisher, RI; Lister, TA; Schwartz, LH; Zucca, E | 1 |
Iida, S; Inagaki, H; Ishida, T; Kusumoto, S; Masaki, A; Mori, F; Suzuki, T | 1 |
Chen, TY; Hsiao, SY | 1 |
Amit, O; Avivi, I; Ben-Ezra, J; Even-Sapir, E; Herishanu, Y; Joffe, E; Kesler, M; Lerman, H; Perry, C; Sarid, N | 1 |
Bier, G; Eigentler, T; Garbe, C; Hoffmann, V; Kloth, C; Klumpp, B; La Fougère, C; Nikolaou, K; Othman, AE; Pfannenberg, C | 1 |
Kang, DY; Lee, JW; Lee, SM; Lee, SY; Na, JO | 1 |
Gobara, H; Iguchi, T; Inai, R; Kanazawa, S; Sato, S; Tada, A; Tanaka, T; Yanai, H | 1 |
Afaq, A; Akin, O; Ardeshna, K; Chen, SH; Fraioli, F; Groves, A; Kayani, I; Lambert, J; Linch, D; Miles, K; Punwani, S; Sidhu, H; Wan, S | 1 |
Goris, ML; Iagaru, A | 1 |
Goudarzi, B; Jacene, HA; Wahl, RL | 1 |
Chen, FY; Gu, HY; Jiang, XX; Wu, LM; Xu, JR; Yin, Y | 1 |
Amati, A; Arena, V; Bellò, M; Bisi, G; Douroukas, A; Passera, R; Pelosi, E; Penna, D | 1 |
Aldridge, M; Almuhaideb, A; Bomanji, JB; Gaze, MN; Papathanasiou, ND; Sullivan, K; Waddington, W | 1 |
Alavi, A; Chamroonrat, W; Chen, W; Cheng, G; Torigian, DA; Zhuang, H | 1 |
Amthauer, H; Becker, M; Ehlert, K; Haberkorn, U; Hasenclever, D; Hundsdörfer, P; Kluge, R; Körholz, D; Kranert, WT; Krausse, A; Kulozik, AE; Mauz-Körholz, C; Purz, S; Rössler, J; Ruschke, K; Sabri, O; Schober, O; Sorge, I; Stiefel, M; Weber, WA | 1 |
Barna, S; Borbély, K; Garai, I; Hascsi, Z; Illés, A; Szûcs, B; Tóth, Z | 1 |
Ahn, JY; Hong, J; Hwang, KH; Jeong, J; Kim, KH; Kim, SG; Lee, JH; Lee, Y; Park, J; Park, S; Park, SH; Park, Y | 1 |
Bashir, H; Faruqui, ZS; Maaz, AU; Mahmood, MT; Mian, M; Mufti, KA; Munir, I; Muzahir, S; Nawaz, MK; Siddiqui, N; Uddin, N | 1 |
Cheng, G | 2 |
Chondrogiannis, S; Evangelista, L; Ferretti, A; Muzzio, PC; Panunzio, A; Polverosi, R; Pomerri, F; Rubello, D | 1 |
Hong, J; Lee, JH | 1 |
Fukuchi, K; Hayashida, K; Ishida, Y; Yamaguchi, M | 1 |
Alavi, A; Chiang, SB; Guan, L; Rebenstock, A; Zhuang, H | 1 |
Ames, JT; Blodgett, TM; McCook, BM; Meltzer, CC; Torok, FS | 1 |
Forero-Torres, A; Mahone, T; Muthukrishnan, A; Ojha, B; Raman, AK; Satya, R | 1 |
Bizais, Y; Botton, E; Conan-Charlet, V; Rest, CC; Robinet, G; Visvikis, D | 1 |
Divgi, C | 1 |
Branquet, D; de Revel, T; Doghmi, K; El Ouennass, M; Fagot, T; Foissaud, V; Forel, A; Malfuson, JV; Nedellec, G; Samson, T | 1 |
Alavi, A; Aydin, A; Yu, JQ; Zhuang, H | 1 |
Hany, TF; Schaefer, NG; Strobel, K; Taverna, C | 1 |
Fukuda, H; Goto, R; Harigae, H; Inoue, K; Kaneta, T; Kato, S; Kinomura, S; Okada, K; Taki, Y | 1 |
Lin, EC | 1 |
Alavi, A; Basu, S | 1 |
Hayasaka, K; Ishigaki, T; Ito, K; Ito, Y; Itou, T; Kato, R; Naganawa, S; Nihashi, T; Sobajima, T | 1 |
Lucignani, G | 1 |
Aupérin, A; Bonniaud, G; Bosq, J; Couanet, D; Edeline, V; Fermé, C; Leboulleux, S; Lumbroso, J; Masson, F; Pigneur, F; Ribrag, V; Schlumberger, M; Vanel, D | 1 |
Al-Nahhas, A; Banti, E; Bianchini, E; D'Andrea, E; Muzzio, PC; Paolini, R; Rubello, D | 1 |
Balan, KK; Seshadri, N; Wright, P | 1 |
Alavi, A; Basu, S; Torigian, D | 1 |
Baghel, NS; Nair, N; Shinto, A | 1 |
Chen, YK; Chi, KH; Ko, HL; Tsang, YW | 1 |
Bisi, G; Chiappella, A; Deandreis, D; Pelosi, E; Penna, D; Skanjeti, A; Vitolo, U | 1 |
Bacharach, SL; Badiee, S; Franc, BL; Hadi, M; Hasegawa, BH; Johnson, L; Lam, T; Seo, Y; Teo, BK | 1 |
Ali, A; Alibazoglu, H; Green, A; Hollinger, EF; Lamonica, G | 1 |
Kim, HC; Kim, HS; Lee, J; Park, CH | 1 |
Asaka, M; Imamura, M; Kato, T; Kobayashi, S; Nishioka, T; Shirato, H; Tamaki, N; Tsukamoto, E; Yamazaki, A | 1 |
Alavi, A; Matthies, A; Schuster, SJ | 1 |
6 review(s) available for fluorodeoxyglucose f18 and Bone Marrow Neoplasms
Article | Year |
---|---|
Role of bone marrow biopsy for staging new patients with Ewing sarcoma: A systematic review.
Topics: Biopsy; Bone Marrow; Bone Marrow Neoplasms; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Sarcoma, Ewing | 2021 |
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.
Topics: 3-Iodobenzylguanidine; Bone Marrow Neoplasms; Bone Neoplasms; Consensus; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Soft Tissue Neoplasms | 2017 |
Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
Topics: Adult; Bone Marrow Neoplasms; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2013 |
Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?
Topics: Biopsy; Bone Marrow; Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2014 |
18F-FDG PET, combined FDG-PET/CT and MRI for evaluation of bone marrow infiltration in staging of lymphoma: a systematic review and meta-analysis.
Topics: Bone Marrow Neoplasms; Comorbidity; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
Usefulness of FDG PET for diagnosis and radiotherapy of the patient with malignant lymphoma involving bone marrow.
Topics: Aged; Bone Marrow Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2007 |
70 other study(ies) available for fluorodeoxyglucose f18 and Bone Marrow Neoplasms
Article | Year |
---|---|
Diagnostic Accuracy and Prognostic Relevance of Immunoglobulin Heavy Chain Rearrangement and 18F-FDG-PET/CT Compared With Unilateral Bone Marrow Trephination for Detecting Bone Marrow Involvement in Patients With Diffuse Large B-Cell Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow Examination; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Gene Rearrangement, B-Lymphocyte, Light Chain; Humans; Immunoglobulin Heavy Chains; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Young Adult | 2022 |
Basosquamous Basal Cell Carcinoma with Bone Marrow Metastasis.
Topics: Bone Marrow Neoplasms; Bone Neoplasms; Carcinoma, Basal Cell; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2022 |
Staging of newly diagnosed Ewing sarcoma: Results of bone marrow aspiration and biopsy versus (18)FDG-PET/CT imaging for bone marrow involvement.
Topics: Biopsy; Bone Marrow; Bone Marrow Neoplasms; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Sarcoma, Ewing | 2023 |
Whole-body three-dimensional short tau inversion recovery and T1-weighted in/opposed phase MRI in the detection of neuroblastoma bone marrow metastasis: comparative study with PET/CT utilising bone marrow biopsy as the reference standard.
Topics: Biopsy; Bone Marrow; Bone Marrow Neoplasms; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuroblastoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Reference Standards; Sensitivity and Specificity; Whole Body Imaging | 2023 |
Diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma.
Topics: Adult; Aged; Bone Marrow Neoplasms; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ilium; Lymphoma, B-Cell; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2020 |
A case of alveolar rhabdomyosarcoma showing concurrent responsive bone marrow lesions and refractory pancreatic lesions to pazopanib monotherapy.
Topics: Adolescent; Bone Density Conservation Agents; Bone Marrow; Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Forkhead Box Protein O1; Humans; Indazoles; Oncogene Proteins, Fusion; Paired Box Transcription Factors; Pancreatic Neoplasms; PAX3 Transcription Factor; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Rhabdomyosarcoma, Alveolar; Sulfonamides; Tumor Microenvironment; Zoledronic Acid | 2020 |
Prominent Bone Marrow Metastases Without Concurrent Intra-Chest Metastasis in a Case of Cardiac Angiosarcoma.
Topics: Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Heart Neoplasms; Hemangiosarcoma; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Primary cardiac angiosarcoma with thrombosis and multiple bone marrow metastases mimicking lymphoma on
Topics: Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thrombosis | 2022 |
Bone Marrow Metastases From Gastric Adenocarcinoma on 68Ga-FAPI-04 PET/CT.
Topics: Adenocarcinoma; Adult; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Quinolines; Stomach Neoplasms | 2022 |
Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
Topics: Adult; Aged; Biopsy; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Ilium; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2017 |
Bone marrow necrosis secondary to metastatic adenocarcinoma revealed by 18F-FDG PET/CT: A clinical case report.
Topics: Adenocarcinoma; Adult; Bone Marrow Neoplasms; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Necrosis; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
PET/CT predicts bone marrow involvement in paediatric non-Hodgkin lymphoma and may preclude the need for bone marrow biopsy in selected patients.
Topics: Adolescent; Adult; Biopsy; Bone Marrow; Bone Marrow Neoplasms; Cell Differentiation; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Lumbar Vertebrae; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2018 |
Diffusion-Weighted Imaging Shows a False-Negative Finding for Bone Marrow Involvement on 18F-FDG PET/MRI in a Patient With Malignant Lymphoma After Blood Transfusion.
Topics: Aged; Bone Marrow Neoplasms; Diffusion Magnetic Resonance Imaging; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Topics: Adolescent; Bone Marrow Neoplasms; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Induction Chemotherapy; Male; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome | 2018 |
FDG PET for Evaluation of Bone Marrow Status in T-Cell Lymphoma.
Topics: Adult; Aged; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
The Value of 18F-FDG PET/CT in Detecting Bone Marrow Involvement in Childhood Cancers.
Topics: Adolescent; Bone Marrow Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Male; Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2019 |
FDG-PET/CT Demonstrates Splenic Angiosarcoma Bone Marrow Metastasis.
Topics: Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Splenic Neoplasms | 2020 |
Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI.
Topics: Aged; Aged, 80 and over; Bone Marrow Neoplasms; Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2013 |
Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging; Young Adult | 2013 |
Bone marrow metastases in an otherwise operable gall bladder cancer: rare site of distant metastases detected on FDG PET/CT.
Topics: Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Increased FDG uptake of the bone marrow mimicking malignancy in a patient of eosinophilia secondary to Sparganum mansoni infection.
Topics: Animals; Biopsy, Needle; Bone Marrow; Bone Marrow Neoplasms; Diagnosis, Differential; Eosinophilia; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Sparganosis; Sparganum; Tomography, X-Ray Computed | 2014 |
PET/CT findings for bone marrow carcinosis because of lung adenocarcinoma.
Topics: Adenocarcinoma; Aged; Bone Marrow Neoplasms; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Bone marrow metastases from alveolar rhabdomyosarcoma with impressive FDG PET/CT finding but less-revealing bone scintigraphy.
Topics: Adult; Bone and Bones; Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Rhabdomyosarcoma, Alveolar; Tomography, X-Ray Computed | 2013 |
Utility of quantitative FDG-PET/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed | 2014 |
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.
Topics: Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; International Cooperation; Liver Neoplasms; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
CD30-positive primary bone marrow lymphoma mimicking Hodgkin lymphoma.
Topics: Aged, 80 and over; Bone Marrow; Bone Marrow Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Immunohistochemistry; Ki-1 Antigen; Lymphoma; Male; Positron-Emission Tomography | 2015 |
Uveal melanoma with diffuse bone marrow involvement.
Topics: Aged; Bone Marrow Neoplasms; Fatal Outcome; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals; Uveal Neoplasms | 2014 |
The Value of PET/CT in Detecting Bone Marrow Involvement in Patients With Follicular Lymphoma.
Topics: Biopsy; Bone Marrow Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2016 |
CT imaging of bone and bone marrow infiltration in malignant melanoma--Challenges and limitations for clinical staging in comparison to 18FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Marrow; Bone Marrow Neoplasms; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2016 |
Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Marrow; Bone Marrow Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2017 |
A Case of Focal Bone Marrow Reconversion Mimicking Bone Metastasis: The Value of 111Indium Chloride.
Topics: Aged; Bone Marrow; Bone Marrow Neoplasms; Carcinoma; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Indium; Male; Positron Emission Tomography Computed Tomography; Tomography, Emission-Computed, Single-Photon | 2016 |
Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Splenic Neoplasms; Young Adult | 2017 |
Rhabdomyosarcoma diffusely metastatic to the bone marrow: suspicious findings on 99mTc-MDP bone scintigraphy confirmed by (18)F-18 FDG PET/CT and bone marrow biopsy.
Topics: Adolescent; Biopsy; Bone and Bones; Bone Marrow Neoplasms; Diffusion; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Rhabdomyosarcoma, Alveolar; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2008 |
Measuring the "unmeasurable": assessment of bone marrow response to therapy using FDG-PET in patients with lymphoma.
Topics: Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2010 |
Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Bone Marrow Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Liver Neoplasms; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival; Survival Analysis; Tomography, Emission-Computed; Young Adult | 2011 |
Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients.
Topics: Adolescent; Bone Marrow Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2011 |
[18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma.
Topics: Adolescent; Biopsy; Bone Marrow Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Neoplasm Staging; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
[18F-FDG PET/CT in lymphomas: assessment difficulties due to illness characteristics, and comparison with literature data].
Topics: Bone Marrow Neoplasms; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma; Muscle Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Survival Analysis; Tomography, X-Ray Computed | 2012 |
Clinical utility of ¹⁸F FDG-PET/CT in the detection of bone marrow disease in Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Bone Marrow Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2012 |
The diagnostic value of FDG-PET cannot be judged by iliac bone marrow biopsy.
Topics: Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Using a cut-off SUV level to define bone marrow lesions on FDG PET is not appropriate.
Topics: Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Early bone marrow metastasis detection: the additional value of FDG-PET/CT vs. CT imaging.
Topics: Aged; Biopsy; Bone Marrow Neoplasms; Cohort Studies; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Italy; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Limitation in the assessment of baseline lymphomatous bone marrow involvement by FDG-PET/CT scan.
Topics: Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Discrepancy between Tc-99m HMDP bone scan and F-18 FDG positron emission tomographic images in a patient with small cell lung cancer.
Topics: Bone Marrow Neoplasms; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Ilium; Lung Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2003 |
Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging.
Topics: Adolescent; Bone Marrow; Bone Marrow Neoplasms; Cytokines; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hematopoiesis; Hodgkin Disease; Humans; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin.
Topics: Aged; Artifacts; Bone Marrow; Bone Marrow Neoplasms; Colorectal Neoplasms; Diagnosis, Differential; Erythropoietin; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Recombinant Proteins; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
Diffuse F-18 FDG uptake in skeletal muscles secondary to chills resulting from sepsis: a cause for underestimation of viable tumor.
Topics: Adult; Bone Marrow Neoplasms; Chills; Diffusion; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Muscle, Skeletal; Positron-Emission Tomography; Radiopharmaceuticals; Sepsis | 2004 |
FDG PET in epithelioid hemangioendothelioma.
Topics: Aged; Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Male; Mediastinal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Imaging: staging and evaluation of lymphoma using nuclear medicine.
Topics: Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2005 |
[Hodgkin's disease with bone marrow involvement. The role of positron tomography].
Topics: Adult; Bone Marrow Neoplasms; Fever; Fluorodeoxyglucose F18; Health Status; Hodgkin Disease; Humans; Male; Pancytopenia; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Detection of bone marrow metastases by FDG-PET and missed by bone scintigraphy in widespread melanoma.
Topics: Adult; Bone Marrow Neoplasms; Bone Neoplasms; Diagnosis, Differential; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Neoplasm Invasiveness; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Bone involvement in patients with lymphoma: the role of FDG-PET/CT.
Topics: Adolescent; Adult; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Diffuse bone marrow uptake on F-18 FDG PET in patients with myelodysplastic syndromes.
Topics: Aged; Bone Marrow; Bone Marrow Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2006 |
FDG PET/CT flip flop phenomenon in treated lymphoma of bone.
Topics: Antineoplastic Agents; Bone Marrow Neoplasms; Bone Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
Bone marrow and not bone is the primary site for skeletal metastasis: critical role of [18F]fluorodeoxyglucose positron emission tomography in this setting.
Topics: Bone and Bones; Bone Marrow Neoplasms; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Neoplasms; Positron-Emission Tomography | 2007 |
Bone and marrow imaging: do we know what we see and do we see what we want to know?
Topics: Bone Marrow Neoplasms; Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Radionuclide Imaging; Radiopharmaceuticals | 2007 |
Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Prednisone; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine; Whole Body Imaging | 2008 |
FDG-PET detection of primary bone marrow large B-cell lymphoma in a patient with hairy cell leukemia.
Topics: Adult; Bone Marrow Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Leukemia, Hairy Cell; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Rhabdomyosarcoma with widespread bone marrow infiltration: beneficial management role of F-18 FDG PET.
Topics: Adolescent; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rhabdomyosarcoma, Alveolar | 2007 |
Evolving concept of imaging bone marrow metastasis in the twenty-first century: critical role of FDG-PET.
Topics: Bone Marrow Neoplasms; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Primitive neuroectodermal tumor with multiple marrow metastases at presentation.
Topics: Adolescent; Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Neuroectodermal Tumors; Positron-Emission Tomography | 2007 |
Submandibular gland carcinoma with unusual widespread bone marrow metastases detected by Tc-99m MDP bone scan and FDG PET.
Topics: Adult; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Submandibular Gland Neoplasms; Technetium Tc 99m Medronate | 2007 |
FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Needle; Bone Marrow; Bone Marrow Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging.
Topics: Adolescent; Adult; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasms; Osteosarcoma; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 1998 |
Dichotomy between Tc-99m MDP bone scan and fluorine-18 fluorodeoxyglucose coincidence detection positron emission tomography in patients with non-Hodgkin's lymphoma.
Topics: Adult; Bone Marrow Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2000 |
Early detection of bone marrow involvement in extramedullary plasmacytoma by whole-body F-18 FDG positron emission tomography.
Topics: Adult; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Neoplasms; Plasmacytoma; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Staging and monitoring response to treatment in primary non-Hodgkin's lymphoma of bone marrow using (18)F-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome; Vincristine | 2001 |